Seasonal impact of PM2.5 on pro-oncogenic drivers among participants of a thermal power plant in India
Molecular epidemiology targeting the impact of particulate matter ≤ 2.5 μm in aerodynamic diameter (PM<sub>2.5</sub>) on pro-oncogenic signaling has been sparsely reported from the Indian industrial belt. This study investigated the effect of seasonal variation in PM<sub>2.5</sub> on pro-oncogenic drivers in the pulmonary and systemic cellular environments of a thermal power plant participants in West Bengal, India during 2021-2022. PM<sub>2.5</sub> levels were significantly higher during spring than monsoon, coinciding with reduced hemoglobin and lung function indices. Linear Mixed-Effects Regression (LMER) confirmed that elevated PM<sub>2.5</sub> exposure was significantly associated with increased inflammatory response, enhanced matrix metalloproteinase-9 (MMP-9) activity, and upregulation of the epidermal growth factor receptor (EGFR)/phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) cascade, along with downregulation of phosphatase and tensin homolog (PTEN). These molecular alterations reflected enhanced proliferative and pro-angiogenic signaling and reduced apoptosis in the airway cells and the leukocytes. Collectively, the findings indicate that short-term seasonal surges in PM<sub>2.5</sub>, may induce subclinical molecular perturbations that predispose exposed individuals in industrial areas to activation of the EGFR/PI3K/AKT pro-oncogenic signaling.
Authors
- Rupa Chaudhuri
- Manjistha Sengupta (ORCID: https://orcid.org/0000-0001-6406-946X)
- Lucas Henneman (ORCID: https://orcid.org/0000-0003-1957-8761)
- Anurima Samanta
- Subhabrata Dey
- Meghna Mukherjee
- Priyanka Saha
- Sukanya Ghosh
- Dona Sinha
Institutions
- George Mason University (US)
- Chittaranjan National Cancer Institute (IN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1038/s41598-025-33906-7
- Primary Topic
- Air Quality and Health Impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chittaranjan National Cancer Institute